The Claim
β-Casomorphin-7 upregulates rMuc2 and rMuc3 expression in rat intestinal cells and MUC5AC expression in human intestinal cells, while having no effect on rMuc1, rMuc4, or rMuc5AC expression in rat intestinal cells, demonstrating a species- and mucin-type-specific regulatory effect on intestinal mucus composition.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
The peptide β-Casomorphin-7 increases the production of specific mucus proteins in intestinal cells from rats and humans, but does not affect other mucus proteins in rat cells, showing that its effect depends on the species and the type of mucus protein.
See the scientific wording
β-Casomorphin-7 selectively upregulates rMuc2 and rMuc3 in rat intestinal cells and MUC5AC in human intestinal cells, but does not affect rMuc1, rMuc4, or rMuc5AC in rat cells, indicating a specific, species- and mucin-type-dependent regulatory effect of this peptide on intestinal mucus composition.
A peptide from milk binds to special receptors on gut mucus-producing cells, turning on only certain genes that make protective mucus proteins, and causes those proteins to be released. This happens in rats for two types of mucus and in humans for one type, but not for other mucus types in either species.
What the research says
1 studyThis study shows that a milk peptide called β-casomorphin-7 makes certain protective mucus molecules in the gut go up — but only the right ones, and only in the right species. It doesn’t affect all mucus, just the ones it’s supposed to.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.